The promising role of miR-296 in human cancer
MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Zhu, Lingling [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Concentration of trisodium citrate by electrodialysis - Fidaleo, Marcello ELSEVIER, 2013, München |
|---|---|
| Übergeordnetes Werk: |
volume:214 ; year:2018 ; number:12 ; pages:1915-1922 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.prp.2018.09.026 |
|---|
| Katalog-ID: |
ELV044997264 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV044997264 | ||
| 003 | DE-627 | ||
| 005 | 20230626010200.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190205s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.prp.2018.09.026 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000433.pica |
| 035 | |a (DE-627)ELV044997264 | ||
| 035 | |a (ELSEVIER)S0344-0338(18)31012-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |q VZ |
| 082 | 0 | 4 | |a 540 |q VZ |
| 084 | |a 35.17 |2 bkl | ||
| 084 | |a 58.50 |2 bkl | ||
| 084 | |a 43.12 |2 bkl | ||
| 100 | 1 | |a Zhu, Lingling |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The promising role of miR-296 in human cancer |
| 264 | 1 | |c 2018transfer abstract | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. | ||
| 520 | |a MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. | ||
| 650 | 7 | |a Target genes |2 Elsevier | |
| 650 | 7 | |a MiR-296 |2 Elsevier | |
| 650 | 7 | |a Cancer |2 Elsevier | |
| 700 | 1 | |a Deng, Hanyu |4 oth | |
| 700 | 1 | |a Hu, Jia |4 oth | |
| 700 | 1 | |a Huang, Shanshan |4 oth | |
| 700 | 1 | |a Xiong, Jianping |4 oth | |
| 700 | 1 | |a Deng, Jun |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Fidaleo, Marcello ELSEVIER |t Concentration of trisodium citrate by electrodialysis |d 2013 |g München |w (DE-627)ELV016908384 |
| 773 | 1 | 8 | |g volume:214 |g year:2018 |g number:12 |g pages:1915-1922 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.prp.2018.09.026 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_70 | ||
| 936 | b | k | |a 35.17 |j Katalyse |q VZ |
| 936 | b | k | |a 58.50 |j Umwelttechnik: Allgemeines |q VZ |
| 936 | b | k | |a 43.12 |j Umweltchemie |q VZ |
| 951 | |a AR | ||
| 952 | |d 214 |j 2018 |e 12 |h 1915-1922 |g 8 | ||
| author_variant |
l z lz |
|---|---|
| matchkey_str |
zhulinglingdenghanyuhujiahuangshanshanxi:2018----:hpoiigoefi26n |
| hierarchy_sort_str |
2018transfer abstract |
| bklnumber |
35.17 58.50 43.12 |
| publishDate |
2018 |
| allfields |
10.1016/j.prp.2018.09.026 doi GBV00000000000433.pica (DE-627)ELV044997264 (ELSEVIER)S0344-0338(18)31012-4 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 35.17 bkl 58.50 bkl 43.12 bkl Zhu, Lingling verfasserin aut The promising role of miR-296 in human cancer 2018transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. Target genes Elsevier MiR-296 Elsevier Cancer Elsevier Deng, Hanyu oth Hu, Jia oth Huang, Shanshan oth Xiong, Jianping oth Deng, Jun oth Enthalten in Elsevier Fidaleo, Marcello ELSEVIER Concentration of trisodium citrate by electrodialysis 2013 München (DE-627)ELV016908384 volume:214 year:2018 number:12 pages:1915-1922 extent:8 https://doi.org/10.1016/j.prp.2018.09.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_70 35.17 Katalyse VZ 58.50 Umwelttechnik: Allgemeines VZ 43.12 Umweltchemie VZ AR 214 2018 12 1915-1922 8 |
| spelling |
10.1016/j.prp.2018.09.026 doi GBV00000000000433.pica (DE-627)ELV044997264 (ELSEVIER)S0344-0338(18)31012-4 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 35.17 bkl 58.50 bkl 43.12 bkl Zhu, Lingling verfasserin aut The promising role of miR-296 in human cancer 2018transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. Target genes Elsevier MiR-296 Elsevier Cancer Elsevier Deng, Hanyu oth Hu, Jia oth Huang, Shanshan oth Xiong, Jianping oth Deng, Jun oth Enthalten in Elsevier Fidaleo, Marcello ELSEVIER Concentration of trisodium citrate by electrodialysis 2013 München (DE-627)ELV016908384 volume:214 year:2018 number:12 pages:1915-1922 extent:8 https://doi.org/10.1016/j.prp.2018.09.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_70 35.17 Katalyse VZ 58.50 Umwelttechnik: Allgemeines VZ 43.12 Umweltchemie VZ AR 214 2018 12 1915-1922 8 |
| allfields_unstemmed |
10.1016/j.prp.2018.09.026 doi GBV00000000000433.pica (DE-627)ELV044997264 (ELSEVIER)S0344-0338(18)31012-4 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 35.17 bkl 58.50 bkl 43.12 bkl Zhu, Lingling verfasserin aut The promising role of miR-296 in human cancer 2018transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. Target genes Elsevier MiR-296 Elsevier Cancer Elsevier Deng, Hanyu oth Hu, Jia oth Huang, Shanshan oth Xiong, Jianping oth Deng, Jun oth Enthalten in Elsevier Fidaleo, Marcello ELSEVIER Concentration of trisodium citrate by electrodialysis 2013 München (DE-627)ELV016908384 volume:214 year:2018 number:12 pages:1915-1922 extent:8 https://doi.org/10.1016/j.prp.2018.09.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_70 35.17 Katalyse VZ 58.50 Umwelttechnik: Allgemeines VZ 43.12 Umweltchemie VZ AR 214 2018 12 1915-1922 8 |
| allfieldsGer |
10.1016/j.prp.2018.09.026 doi GBV00000000000433.pica (DE-627)ELV044997264 (ELSEVIER)S0344-0338(18)31012-4 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 35.17 bkl 58.50 bkl 43.12 bkl Zhu, Lingling verfasserin aut The promising role of miR-296 in human cancer 2018transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. Target genes Elsevier MiR-296 Elsevier Cancer Elsevier Deng, Hanyu oth Hu, Jia oth Huang, Shanshan oth Xiong, Jianping oth Deng, Jun oth Enthalten in Elsevier Fidaleo, Marcello ELSEVIER Concentration of trisodium citrate by electrodialysis 2013 München (DE-627)ELV016908384 volume:214 year:2018 number:12 pages:1915-1922 extent:8 https://doi.org/10.1016/j.prp.2018.09.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_70 35.17 Katalyse VZ 58.50 Umwelttechnik: Allgemeines VZ 43.12 Umweltchemie VZ AR 214 2018 12 1915-1922 8 |
| allfieldsSound |
10.1016/j.prp.2018.09.026 doi GBV00000000000433.pica (DE-627)ELV044997264 (ELSEVIER)S0344-0338(18)31012-4 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 35.17 bkl 58.50 bkl 43.12 bkl Zhu, Lingling verfasserin aut The promising role of miR-296 in human cancer 2018transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. Target genes Elsevier MiR-296 Elsevier Cancer Elsevier Deng, Hanyu oth Hu, Jia oth Huang, Shanshan oth Xiong, Jianping oth Deng, Jun oth Enthalten in Elsevier Fidaleo, Marcello ELSEVIER Concentration of trisodium citrate by electrodialysis 2013 München (DE-627)ELV016908384 volume:214 year:2018 number:12 pages:1915-1922 extent:8 https://doi.org/10.1016/j.prp.2018.09.026 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_70 35.17 Katalyse VZ 58.50 Umwelttechnik: Allgemeines VZ 43.12 Umweltchemie VZ AR 214 2018 12 1915-1922 8 |
| language |
English |
| source |
Enthalten in Concentration of trisodium citrate by electrodialysis München volume:214 year:2018 number:12 pages:1915-1922 extent:8 |
| sourceStr |
Enthalten in Concentration of trisodium citrate by electrodialysis München volume:214 year:2018 number:12 pages:1915-1922 extent:8 |
| format_phy_str_mv |
Article |
| bklname |
Katalyse Umwelttechnik: Allgemeines Umweltchemie |
| institution |
findex.gbv.de |
| topic_facet |
Target genes MiR-296 Cancer |
| dewey-raw |
570 |
| isfreeaccess_bool |
false |
| container_title |
Concentration of trisodium citrate by electrodialysis |
| authorswithroles_txt_mv |
Zhu, Lingling @@aut@@ Deng, Hanyu @@oth@@ Hu, Jia @@oth@@ Huang, Shanshan @@oth@@ Xiong, Jianping @@oth@@ Deng, Jun @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV016908384 |
| dewey-sort |
3570 |
| id |
ELV044997264 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV044997264</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626010200.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">190205s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.prp.2018.09.026</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000433.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV044997264</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0344-0338(18)31012-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.17</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.50</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zhu, Lingling</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The promising role of miR-296 in human cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Target genes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MiR-296</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Deng, Hanyu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hu, Jia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huang, Shanshan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Xiong, Jianping</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Deng, Jun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Fidaleo, Marcello ELSEVIER</subfield><subfield code="t">Concentration of trisodium citrate by electrodialysis</subfield><subfield code="d">2013</subfield><subfield code="g">München</subfield><subfield code="w">(DE-627)ELV016908384</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:214</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:1915-1922</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.prp.2018.09.026</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.17</subfield><subfield code="j">Katalyse</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.50</subfield><subfield code="j">Umwelttechnik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">214</subfield><subfield code="j">2018</subfield><subfield code="e">12</subfield><subfield code="h">1915-1922</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| author |
Zhu, Lingling |
| spellingShingle |
Zhu, Lingling ddc 570 ddc 540 bkl 35.17 bkl 58.50 bkl 43.12 Elsevier Target genes Elsevier MiR-296 Elsevier Cancer The promising role of miR-296 in human cancer |
| authorStr |
Zhu, Lingling |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV016908384 |
| format |
electronic Article |
| dewey-ones |
570 - Life sciences; biology 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
570 VZ 540 VZ 35.17 bkl 58.50 bkl 43.12 bkl The promising role of miR-296 in human cancer Target genes Elsevier MiR-296 Elsevier Cancer Elsevier |
| topic |
ddc 570 ddc 540 bkl 35.17 bkl 58.50 bkl 43.12 Elsevier Target genes Elsevier MiR-296 Elsevier Cancer |
| topic_unstemmed |
ddc 570 ddc 540 bkl 35.17 bkl 58.50 bkl 43.12 Elsevier Target genes Elsevier MiR-296 Elsevier Cancer |
| topic_browse |
ddc 570 ddc 540 bkl 35.17 bkl 58.50 bkl 43.12 Elsevier Target genes Elsevier MiR-296 Elsevier Cancer |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
h d hd j h jh s h sh j x jx j d jd |
| hierarchy_parent_title |
Concentration of trisodium citrate by electrodialysis |
| hierarchy_parent_id |
ELV016908384 |
| dewey-tens |
570 - Life sciences; biology 540 - Chemistry |
| hierarchy_top_title |
Concentration of trisodium citrate by electrodialysis |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV016908384 |
| title |
The promising role of miR-296 in human cancer |
| ctrlnum |
(DE-627)ELV044997264 (ELSEVIER)S0344-0338(18)31012-4 |
| title_full |
The promising role of miR-296 in human cancer |
| author_sort |
Zhu, Lingling |
| journal |
Concentration of trisodium citrate by electrodialysis |
| journalStr |
Concentration of trisodium citrate by electrodialysis |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
1915 |
| author_browse |
Zhu, Lingling |
| container_volume |
214 |
| physical |
8 |
| class |
570 VZ 540 VZ 35.17 bkl 58.50 bkl 43.12 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Zhu, Lingling |
| doi_str_mv |
10.1016/j.prp.2018.09.026 |
| dewey-full |
570 540 |
| title_sort |
promising role of mir-296 in human cancer |
| title_auth |
The promising role of miR-296 in human cancer |
| abstract |
MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. |
| abstractGer |
MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. |
| abstract_unstemmed |
MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_70 |
| container_issue |
12 |
| title_short |
The promising role of miR-296 in human cancer |
| url |
https://doi.org/10.1016/j.prp.2018.09.026 |
| remote_bool |
true |
| author2 |
Deng, Hanyu Hu, Jia Huang, Shanshan Xiong, Jianping Deng, Jun |
| author2Str |
Deng, Hanyu Hu, Jia Huang, Shanshan Xiong, Jianping Deng, Jun |
| ppnlink |
ELV016908384 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/j.prp.2018.09.026 |
| up_date |
2024-07-06T22:57:49.254Z |
| _version_ |
1803872286020730880 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV044997264</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626010200.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">190205s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.prp.2018.09.026</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000433.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV044997264</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0344-0338(18)31012-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.17</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.50</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zhu, Lingling</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The promising role of miR-296 in human cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">MicroRNAs (MiRNAs) are small non–protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial–mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Target genes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MiR-296</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Deng, Hanyu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hu, Jia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huang, Shanshan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Xiong, Jianping</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Deng, Jun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Fidaleo, Marcello ELSEVIER</subfield><subfield code="t">Concentration of trisodium citrate by electrodialysis</subfield><subfield code="d">2013</subfield><subfield code="g">München</subfield><subfield code="w">(DE-627)ELV016908384</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:214</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:1915-1922</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.prp.2018.09.026</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.17</subfield><subfield code="j">Katalyse</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.50</subfield><subfield code="j">Umwelttechnik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">214</subfield><subfield code="j">2018</subfield><subfield code="e">12</subfield><subfield code="h">1915-1922</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| score |
7.4000406 |